2021 Interactive Breakout Discussions

Join a virtual breakout discussion group. These are informal, moderated discussions with brainstorming and interactive problem solving, allowing participants from diverse backgrounds to exchange ideas and experiences and develop future collaborations around a focused topic. This year’s breakouts will take place on Thursday, June 17, 3:00 - 3:35 pm (EDT) AND Friday, June 18, 10:30 - 11:00 am (EDT).

THURSDAY, JUNE 17 | 3:00 - 3:35 PM

TABLE 1: Biodetection In the Real World
Chris Taitt, PhD, Research Biochemist, Center for Biomolecular Science & Engineering, U.S. Naval Research Lab

  • Testing in advance of deployment - what is the best strategy?
  • Are abbreviated instructions sufficient to inform technicians and how do we account for mis-handling, untrained users?
  • How can we decrease costs associated with development, manufacturing, and testing so that tests are affordable by developing nations?
  • How can we account for underlying health issues encountered in developing nations?

TABLE 2: Detecting Infectious Disease Threats (IDTs) Where it is Needed
Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.

  • Periodically previously unknown infectious diseases emerge to affect human, animals and plants; similarly, pathogens present in a population at low levels have re-emerged rapidly in incidence and geographic range with equally grave consequences.
  • Given the dynamics of environmental change, travel and the ability of different governments to detect IDTs is key to develop integrative policies to accurately detect infectious diseases.
  • The challenges that more 1500 IDTs pose to human, animal or plant health and how different technologies can be applied in diverse operational environments.
  • What are the practical requirements, regulatory issues and policy challenges.

TABLE 3: Epic Failures in Research And Development; Share Your Experience To Help Others Feel Better About Themselves
Dave Alburty, CEO, Engineering, InnovaPrep

  • What happened?
  • What was learned?
  • Would you try it again?
  • Did it lead to something else that was great?
  • Was there collateral damage or benefits?
  • How much did it cost?

FRIDAY, JUNE 18 | 10:30 - 11:00 AM

TABLE 1: How to Deal with Using Microbial Genomics to Identify Potential Bioterrorism Attacks
David Ussery, PhD, Director ArC GEM & Professor, Biomedical Informatics, University of Arkansas for Medical Sciences

  • How do we address the issue with taxonomy, which has been rapidly changing
  • How do we classify potential pathogens “in the wild’, vs. ’terrorist GMOs’ vs. ‘environmental harmless bacteria’ is not as easy as it sounds

TABLE 2: Questions to Consider Before Positioning Your Technology for Adoption
Joany Jackman, PhD, Senior Scientist, Research & Exploratory Development, Johns Hopkins University

  • Do you have a clear idea of how your technology and the results provided be used?
  • Who will interpret the results of your test?
  • How will your test change the current patient treatment or management?
  • What does the current patient flow look like and will your test change this?

TABLE 3: Agnostic Biosensing - Removing the Situational and Syndromic Components of Biodetection and Diagnostics
Harshini Mukundan, PhD, Principal Investigator & Team Leader, Chemistry for Biomedical Applications, Los Alamos National Lab

  • What are the syndromic and situational information that influence diagnostics and detection
  • What is the cost of this bias - in terms of decisions on the choice of sample, method, assay, and time to result
  • Strategies to remove the bias from the diagnostics equation
  • Role of big data and analytics in this response